Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Nov 1;110(9):3326-33.
doi: 10.1182/blood-2007-05-091561. Epub 2007 Aug 8.

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Affiliations
Multicenter Study

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Gabrielle S Sellick et al. Blood. .

Abstract

Chronic lymphocytic leukemia (CLL) and other B-cell lymphoproliferative disorders display familial aggregation. To identify a susceptibility gene for CLL, we assembled families from the major European (ICLLC) and American (GEC) consortia to conduct a genome-wide linkage analysis of 101 new CLL pedigrees using a high-density single nucleotide polymorphism (SNP) array and combined the results with data from our previously reported analysis of 105 families. Here, we report on the combined analysis of the 206 families. Multipoint linkage analyses were undertaken using both nonparametric (model-free) and parametric (model-based) methods. After the removal of high linkage disequilibrium SNPs, we obtained a maximum nonparametric linkage (NPL) score of 3.02 (P = .001) on chromosome 2q21.2. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a common recessive model of disease susceptibility (HLOD = 3.11; P = 7.7 x 10(-5)), which was significant at the genome-wide level. In addition, 2 other chromosomal positions, 6p22.1 (corresponding to the major histocompatibility locus) and 18q21.1, displayed HLOD scores higher than 2.1 (P < .002). None of the regions coincided with areas of common chromosomal abnormalities frequently observed in CLL. These findings provide direct evidence for Mendelian predisposition to CLL and evidence for the location of disease loci.

PubMed Disclaimer

Figures

Figure 1
Figure 1
NPL scores across each chromosome. In each plot, ---- shows NPL statistics obtained using all SNPs (with LD; n = 9690), while ▔ shows NPL statistics obtained after exclusion of high-LD SNPs (n = 7495).
Figure 2
Figure 2
Plots of transformed linkage statistics (−log10[P value]) after the removal of high-LD SNPs for chromosomes 2, 5, 6, 11, and 18. Transformed HLOD scores under the best dominant model are shown in black; under the best recessive model, in red; and transformed NPL values, in blue. The best recessive model for each of the 5 chromosomes was chromosomes 2, 6, and 18 (common recessive) and chromosomes 5 and 11 (rare recessive). The best dominant model for each of the 5 chromosomes was chromosomes 2, 6, and 11 (common dominant) and chromosomes 5 and 18 (rare dominant).

References

    1. Stevenson F, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood. 2004:4389–4395. - PubMed
    1. Yuille MR, Matutes E, Marossy A, Hilditch B, Catovsky D, Houlston RS. Familial chronic lymphocytic leukaemia: a survey and review of published studies. Br J Haematol. 2000;109:794–799. - PubMed
    1. Jonsson V, Houlston RS, Catovsky D, et al. CLL family ‘Pedigree 14′ revisited: 1947–2004. Leukemia. 2005;19:1025–1028. - PubMed
    1. Aoun P, Zhou G, Chan WC, et al. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage. Am J Clin Pathol. 2007;127:31–38. - PubMed
    1. Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104:1850–1854. - PubMed

Publication types